Geron Stock Soars 20 Percent on Approval of Clinical Trials
Today is a big, big day for California's Geron Corp., which has received federal approval to begin "the world's first study of a treatment based on human embryonic stem cells."
The Associated Press covered the basics of the action. An early version of its story said said,
"The company gained federal permission this week to inject eight to 10 patients with…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.